← Back to Search

Cognitive Training

Computer Cognitive Training for Post-COVID Syndrome (PACS-Cog Trial)

N/A
Recruiting
Led By Raymond L Ownby, MD, PhD
Research Sponsored by Nova Southeastern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Persons with a history of COVID-19 infection confirmed through screening of symptom pattern or testing and report of mental symptoms (difficulties in attention, memory, or executive functions such as coordinating two activities at once) more than 30 days after resolution of the initial acute infection.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three weeks
Awards & highlights

PACS-Cog Trial Summary

This trial will test if a computer game can help people with COVID-related cognitive issues.

Who is the study for?
This trial is for individuals who had COVID-19 and are experiencing ongoing cognitive symptoms like trouble with attention, memory, or multitasking more than a month after their initial recovery. Participants must be able to give informed consent and cooperate with the study requirements.Check my eligibility
What is being tested?
The study is testing a game-based computer program designed to improve thinking skills in people suffering from long-term cognitive issues following COVID-19 infection. It aims to see if this digital cognitive training is practical, enjoyable, and effective.See study design
What are the potential side effects?
Since the intervention involves non-invasive cognitive training games on a computer, there are no direct physical side effects expected from participating in this trial.

PACS-Cog Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had COVID-19 and have experienced mental symptoms like memory or attention issues more than 30 days after recovering.

PACS-Cog Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and three weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Technology Acceptance Model Questionnaire, Usefulness subscale
Secondary outcome measures
Cognitive Failures Questionnaire
Trail Making Test, Part B

PACS-Cog Trial Design

1Treatment groups
Experimental Treatment
Group I: Cognitive TrainingExperimental Treatment1 Intervention
Participants in this condition will received game-based cognitive training.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Training
2008
Completed Phase 3
~4100

Find a Location

Who is running the clinical trial?

Nova Southeastern UniversityLead Sponsor
89 Previous Clinical Trials
11,633 Total Patients Enrolled
Raymond L Ownby, MD, PhDPrincipal InvestigatorNova Southeastern University
5 Previous Clinical Trials
544 Total Patients Enrolled

Media Library

Computer Cognitive Training (Cognitive Training) Clinical Trial Eligibility Overview. Trial Name: NCT05338749 — N/A
Cognitive Impairment Research Study Groups: Cognitive Training
Cognitive Impairment Clinical Trial 2023: Computer Cognitive Training Highlights & Side Effects. Trial Name: NCT05338749 — N/A
Computer Cognitive Training (Cognitive Training) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05338749 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an ongoing recruitment of participants for this research?

"Affirmative. The clinical trial, initially posted on April 26th 2022 and recently updated on August 9th 2022, is actively searching for 10 participants from 1 medical centre. This information can be found via the clinicaltrials.gov website."

Answered by AI

What is the current scope of participation for this research?

"Affirmative, the information available on clinicaltrials.gov indicates that this research is currently recruiting. The trial was originally listed on April 26th 2022 and has since been refreshed as of August 9th 2022. Ten patients are sought from one medical facility for enrollment in this experiment."

Answered by AI
~1 spots leftby Jun 2024